1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
The DOD PRMRP Discovery Award for Antimicrobial Resistance is a grant from the Department of Defense Congressionally Directed Medical Research Programs (CDMRP) that funds early-stage, high-risk, high-reward research into antimicrobial resistance.
The Discovery Award mechanism supports innovative research concepts that could lead to significant advances in prevention, diagnosis, or treatment of drug-resistant infections affecting military personnel and the public. Awards total $200,000. Eligible applicants include universities and research organizations.
The most recent application deadline was May 15, 2025. Researchers working on novel approaches to combat antimicrobial resistance are encouraged to apply.
Get alerted about grants like this
Get emailed when new opportunities from “Department of Defense (CDMRP)” or related funders appear. Free, weekly, unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Peer Reviewed Medical, Congressionally Directed Medical Research Programs You are using an outdated browser. Please upgrade your browser to improve your experience. U.S. Department of War organization.
Lapse in Federal Appropriations The most recent appropriations for the Department of War expired at 11:59 p. m. EST on September 30, 2025.
Military personnel will continue in a normal duty status without pay until such time as a continuing resolution or appropriations are passed by Congress and signed into law. Civilian personnel not engaged in excepted activities will be placed in a non-work, non-pay status. Visit www.
dha. mil/shutdown for more information.
DEPARTMENT OF WAR - CONGRESSIONALLY DIRECTED MEDICAL RESEARCH PROGRAMS Transforming Health Care through Innovative and Impactful Research Vision – Improve the health, care, and well-being of all military Service Members, Veterans, and their families Mission – Encourage, identify, select and manage medical research projects of clear scientific merit that lead to impactful advances in health care of Service Members, Veterans and their Families.
» Click on Image to View Program Summary Sheet » Click on Image to View Program Glitz Sheet The Peer Reviewed Medical Research Program (PRMRP), established in fiscal year 1999 (FY99), has supported research across the full range of science and medicine, with an underlying goal of enhancing the health, care, and well-being of military Service members, Veterans, retirees, and their family members.
Program oversight is provided by a programmatic panel with joint military service and interagency representation. Congressional appropriations for the PRMRP totaled $2. 35 billion through FY19 and have supported over 1600 awards in over 155 different topic areas.
Congress appropriated $360 million for the FY20 program to solicit proposals in 44 topic areas. Throughout history, military medical research has pioneered breakthroughs in reconstructive surgery, the use of antibiotics, intensive care, burn care, and kidney dialysis in response to war time needs, benefitting Service members and civilians alike.
Medical research supported by the PRMRP to address near-term military needs including military and personal readiness, continues this tradition.
The PRMRP is committed to supporting research that has the potential to profoundly impact the development and implementation of medical devices, drugs, and clinical guidance that will enhance the precision and efficacy of prevention, diagnosis, and treatment across a wide range of disciplines including autoimmune diseases and immunology, cardiovascular health, endocrine health and metabolism, environmental health, infectious diseases, internal medicine, neurological and psychological health, orthopedic and regenerative medicine, and respiratory health and injury.
Congressional Appropriations Topic Areas Offered by Year (FY21-26) Recent Applications Recommended for Funding FY25 Peer Review Participants (pdf) CDMRP-Supported Research Assesses TBI-Related Outcomes to Improve Warfighter Brain Health CDMRP Funds Research to Accelerate Treatments for Rare Diseases to Support Warfighters and their Families FY25 PRMRP Recommended for Funding List CDMRP-Funded Research Supports Suicide Prevention and Total Force Readiness Peer Reviewed Medical Research Program Booklet CDMRP Funds Research to Reduce Opioid Use in Veterans and Service Members with Chronic Pain CDMRP Contributed to Research Leading to FDA Clearance of Traumatic Brain Injury Diagnostic Tool Kelsey Smith: Advocacy for People with Celiac Disease Amidst Growing Popularity for a Gluten-Free Diet Peter Fiduccia: The Importance of Polycystic Kidney Disease Developing an Effective Treatment Option for Pancreatitis The Walking, Talking Kidney: Bill Brazell More Consumer Stories… Fighting Neuroblastoma with a Multi-Pronged Attack on Polyamines Click here to provide feedback/comments to the PRMRP Last updated Monday, March 23, 2026
According to the current listing, eligibility includes: Universities and research organizations. Confirm the full requirements in the official notice before applying.
The current listing shows $200,000. Verify award ceilings, matching requirements, and allowable costs in the official notice.
The most recent published deadline was July 30, 2026, which has passed. This is an annual program, so a new cycle should follow. Check the funder's website for the next application window.
DOD PRMRP Discovery Award - Antimicrobial Resistance is funded by Department of Defense (CDMRP). Verify program details on the funder's official page before applying.
Yes — this listing is flagged as national in scope, so applicants across the U.S. may apply, subject to the sponsor's other eligibility criteria.
Applications go through the funder's official portal — the Apply Now link on this page goes there directly.
The Department's FY26 SBIR/STTR Release 3 opened June 24 with roughly 37 topics across DARPA, the Navy, the Air Force, and the defense components, all closing July 22. The compressed four-week window is unforgiving, but the bigger mistake founders make is treating every component the same. Here is how to read the release, the eligibility rules that disqualify good companies, and why the component you target matters more than the topic you pick.
Read articleDoW's 2026 SBIR Broad Agency Announcement now operates on a monthly pre-release / quarterly close cadence. The 42 topics closing June 24 are the first test of whether the new rhythm produces the steady-state deal flow defense innovators have been asking for since 2022.
Read articleBioMADE just funded 14 projects spanning lithium extraction, AI-driven protein engineering, and veteran workforce programs. The first-ever NSF partnership changes how basic research reaches production.
Read article